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INTRODUCTION 
Chronic pancreatitis is defined as a chronic inflammatory disease, characterised by 
irreversible, progressive destruction of pancreatic tissue, with dynamic progressive 
fibrosis of pancreas, leading to progressive loss of both exocrine and endocrine 
function. Until the 1940s, it was thought to be a rare disease; knowledge of its 
natural history was fragmentary; and it was usually recognised only at autopsy. In 
1946 and 1948 Comfort and his associates at the Mayo clinic gave the first, 
comprehensive clinical and pathological description of the disease and emphasized 
its association with diseases of the biliary tract and with alcoholism. The publication 
of these papers, along with the introduction of the secretin test of exocrine 
pancreatic function, led to the clinical diagnosis of increasing number of patients 
with chronic pancreatitis, and to a proliferation of various surgical procedures for 
this condition. The second milestone was reached in 1963 during a symposium of 
European gastroenterologists in Marseilles, where a simple classification of chronic 
pancreatitis was adopted, that replaced a bewildering array of terms and definitions, 
and has since been widely accepted.  
 
In a tropical country like India, the commonest cause for chronic pancreatitis is 
alcoholism. The disease is prevalent in Kerala and in northern parts of the country. 
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The purpose of this thesis is to report observations made on cases admitted with 
chronic pancreatitis during our study period, and to discuss it in the light of 
available literature, and to suggest methods for an early diagnosis, its preventive 
methods, and management of chronic pancreatitis.  
  
14 
 
 
AIM OF THIS STUDY 
 
1. To recognise the various causative factors responsible for the disease process,  
2. To analyse the various methods of presentation of chronic pancreatitis,  
3. To evaluate the various indications for surgical interventions, and  
4. To assess the results of surgical treatment. 
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MATERIALS AND METHODS 
 
The patients admitted in Thanjavur Medical College Hospital, Thanjavur, during the 
period from September 2016 to August 2017, and their subsequent follow up at our 
outpatient department were studied. Their history, clinical presentation, 
investigations and management were recorded. From these data, the various aspects 
of chronic pancreatitis were studied.  
 
The following investigations were done for diagnosis and evaluation of chronic 
pancreatitis.  
 Urine sugar  
 Blood sugar  
 Serum calcium  
 amylase   
 Plain X-ray abdomen  
 Ultrasonogram abdomen  
 CT-abdomen  
We present here, our data on chronic pancreatitis, as seen by our surgery department  
Thanjavur Medical College Hospital, Thanjavur. 
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REVIEW OF LITERATURE  
ANATOMY  
In shape, the gland resembles the upper end of a thick walking-stick, lying sideways 
with the handle on the right. Its length is about 15 cms. The gland is of firm 
consistency. Its surface is finely lobulated. Its big head on the right is connected by 
a short neck to the body, which crosses the midline and tapers to a narrow tail on the 
left. The transpyloric plane (L1) is the guide to the surface marking, the neck lies on 
the plane.  
H. Durmen has summarized the anatomical relationship of the pancreas as follows: 
‘The pancreas cuddles the left kidney, tickles the spleen, hugs the duodenum, 
cradles the aorta, opposes the inferior vena cava, dallies with the right renal pedicle, 
hides behind the posterior parietal peritoneum of the lesser sac and wraps itself 
around the superior mesenteric vessels’. The pancreas is relatively inaccessible and, 
without some dissection, very little of it can be seen or palpated even at laparotomy. 
For this reason, it is much more difficult to manage surgically than all other 
abdominal viscera. Its retroperitoneal location in the upper abdomen means that, it is 
almost completely hidden by the stomach, transverse colon and mesocolon. 
 
The head, the broadest part of the pancreas, is moulded to the C-shaped concavity of 
the duodenum. It lies at the level of L2 vertebra. The lower part of the posterior 
surface has a hook - shaped extension upwards, the uncinate process. 
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The neck, is best defined as the narrow band of pancreatic tissue that lies in front of 
the commencement of the portal vein, continuous to the right with the head, and to 
the left with the body.  
The body, passes from the neck to the left, sloping upwards. The body is triangular 
in cross - section.  
The tail, is accompanied by the splenic artery, vein and lymphatics, lies within the 
two layers of the lienorenal ligament and thus reaches the hilum of the spleem. 
The Pancreatic duct (of Wirsung) is a continuous tube leading from the tail to the 
head. It drains most of the pancreas, except for the uncinate process & lower part of 
the head, which drains by the accessory pancreatic duct (of Santorini).  
 
Blood supply  
The main vessel is the splenic artery, which supplies the neck, body & tail. The head 
is supplied by the superior and the inferior pancreaticoduodenal arteries. Venous 
return is by numerous small veins into the splenic vein and, in the case of the head, 
by the superior pancreaticoduodenal vein into the portal vein and by the inferior 
pancreaticoduodenal vein into the superior mesenteric vein. 
 
Lymph drainage  
Lymphatics from the pancreas follow the course of the arteries. To the left of the 
neck, the pancreas drains into the pancreaticosplenic nodes. The head drains into the 
coeliac and superior mesenteric group of lymph nodes.  
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Nerve supply  
Parasympathetic vagal fibres stimulating exocrine secretion, reach the gland from 
the posterior vagal trunk and coeliac plexus. Sympathetic vasoconstrictor impulses 
are derived from spinal cord segments T6-l0  via splanchnic nerves and the coeliac 
plexus. Pain fibres accompany the sympathetic supply. 
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PHYSIOLOGY  
The pancreas is a composite gland, having both exocrine acini and groups  of 
endocrine cells. Exocrine pancreas The pancreatic juice contains enzymes that are of 
major importance in digestion. The portion of the pancreas that secretes pancreatic 
juice is a compound alveolar gland. Granules containing the digestive enzymes 
(Zymogen granules) are formed in the cell and discharged by exocytosis. The 
pancreatic juice is alkaline, and has a high bicarbonate content. About 1500 ml of 
pancreatic juice is secreted per day. The powerful protein - splitting enzymes of the 
pancreatic juice are secreted as inactive proenzymes. Trypsinogen is converted to 
the active enzyme trypsin by the brush border enzyme enteropeptidase 
(enterokinase) when the pancreatic juice enters the duodenum. Trypsin converts 
chymotrypsinogen into chymotrypsin and other proenzymes into active enzymes. 
Trypsin can also activate trypsinogen; therefore once some trypsin is formed, there 
is an auto catalytic chain reaction.  
Regulation of the secretion of pancreatic juice: Secretion of pancreatic juice is 
primarily under hormonal control. Secretin acts on the pancreatic ducts to cause 
copious secretion of a very alkaline pancreatic juice that is rich in bicarbonate and 
poor in enzymes. CCK acts on the acinar cells to cause the release of zymogen 
granules and production of pancreatic juice rich in enzymes. Like CCK, 
acetyicholine acts on the acinar cells via phospholipase-C to cause discharge of 
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zymogen granules, and stimulation of the vagi causes secretion of a small  amount 
of pancreatic juice rich in enzymes. 
 
Endocrine Pancreas  
Atleast 4 peptides with hormonal activity are secreted by the islets of Langerhans in 
the pancreas. Two of these hormones, insulin and glucagon, have important 
functions in the regulation of the intermediary metabolism of carbohydrates, protein 
and fat. The third hormone, somatostatin plays a role in the regulation of islet cell 
secretion. The fourth, pancreatic polypeptide, is probably concerned with 
gastrointestinal function. Insulin is anabolic, increasing the storage of glucose,fatty 
acids and aminoacids. Glucagon is catabolic, mobilising glucose, fatty acid and 
aminoacid from stores into blood stream. The :slets of Langerhans are collection of 
cells scattered throughout the pancreas, although they are more plentiful in the tail 
than in the body and head. They make up 1-2% of the weight of the pancreas. There 
are 1-2 million islets in humans. Each has a copious blood supply and blood from 
islets drains into the hepatic portal vein.  
Based on their staining properties and morphology, there are atleast four distinct cell 
types in humans: A,B,D,and F cells. The A cells secrete glucagon, B cells secrete 
Insulin, the D cells secrete somatostatin, and the F cells secrete creatic polypeptide. 
The B cells, which are the most common and account for 60 - 75 % of the cells in 
the islets, are generally located in the centre of each islet. They tend to be 
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surrounded by the A cells, which make up 20% of the total, and less common D and 
F cells. 
PATHOLOGY  
The chief distinction between acute and chronic pancreatitis is whether the pancreas 
is normal before a symptomatic attack or already chronically damaged. This 
distinction remains blurred, and thus the pathogenic mechanisms in these disorders 
may overlap. In acute pancreatitis, the normal architecture of the gland is restored 
after the acute attack, whereas in chronic pancreatitis, restoration of normal 
glandular architexture is not possible, and it does not take place.  
Early in the disease, the pancreas may be grossly normal in appearance. As the 
disease progresses, the pancreas may become enlarged, indurated and edematous 
from recent attacks of acute inflammation. The duct may still be normal, or there 
may be slight dilatation of the main duct and one or two of its tributaries. When the 
disease is far advanced, the pancreas is usually small and may be reduced to a 
contracted cord, no more than 2 to 3 cm in diameter. Its edges are characteristically 
rounded. It may have a rubbery or rock hard consistency. Ductal stones are 
frequently present. They vary in size from less than a millimeter to more than a 
centimeter in diameter. All pancreatic calcifications are actually intraductal in 
location. Thus, the size of a stone seen on plain abdominal film provides 
information about the minimal diameter of the pancreatic duct in which it must 
reside. 
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Aetiology of chronic pancreatitis  
1 Alcoholic chronic 
pancreatitis 
 
2 Nutritional factors and 
chronic pancreatitis  
High fat & high protein diet  
Tropical pancreatitis  
CP and  Kwashiorkor.  
3 Obstructive chronic 
pancreatitis   
Pancreas divisum 
Obstruction due to neoplasia  
Obstruction due to ductal strictures   
Miscellaneous causes of obstruction  
4 Chronic pancreatitis  
associated with 
metabolic disorders  
Hyperkalaemia  
Hyperlipidaemia  
5 Familial (Heriditary) 
chronic pancreatitis  
 
6 Idiopathic chronic 
pancreatitis  
 
7 Chronic pancreatitis and 
biliary tract disease  
 
8 Miscellaneous causes  Abdominal radiotherapy  
Cystic fibrosis  
Primary biliary cirrhosis  
Ulcerative colitis  
Trauma  
Hemochromatosis  
Alcoholic chronic pancreatitis  
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Alcohol as a cause of chronic pancreatitis accounts for about 75% of cases. There is 
a linear relationship between alcohol consumption and the logarithmic relative risk 
of developing chronic pancreatitis. The increasing incidence of chronic pancreatitis 
parallels an increase in alcohol consumption. Alcoholics who smoke appear to be at 
particularly high risk. No threshold toxic daily dose of alcohol has been defined. 
The fact that individual sensitivity appears to vary suggests that some individuals 
have a genetic predisposition to alcohol- induced pancreatic damage. However, the 
average daily intake of pure alcohol of those affected usually exceeds 60-80g, and 
women seem to have a greater sensitivity to the toxic effects of alcohol.  
Alcoholic chronic pancreatitis typically becomes manifest by the middle or end of 
the fourth decade. The duration of substantial alcohol consumption averages 17-18 
years in men and 10-12 years in women.  
Once initiated, ductal changes may progress, even though the patient abstains or 
reduces alcohol intake. Pancreatic calcification increases with disease duration. 
Although only a minority of alcoholics develop clinical pancreatitis, morphologica1 
changes are found at autopsy in 19-58% of alcohol abusers. Calcification is not 
necessarily associated with marked exocrine or endocrine insufficiency. Ductal 
decompression often produces striking dissolution of pancreatic calcification. 
Three major hypothesis have been formulated to explain the damaging effects of 
alcohol on the pancreas. Of the three, the flow/reflux hypothesis offers the least 
convincing explanation. The disease is almost certainly caused by interplay of many 
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factors, but interaction of metabolic and toxic factors, altered exocrine secretion, 
and genetically determined sensitivity to alcohol are probably the key determinants.  
 
Flow/reflux hypothesis:  
This hypothesis postulates that alcohol reduces tone in the sphincter of Oddi and 
allows reflux of duodenal juice, which contains activated pancreatic enzymes.  
An alternative version of this hypothesis proposes that alcohol causes spasm of the 
sphincter, thus allowing bile to reflux into the pancreatic duct.  
 
Ductal plug hypothesis:  
Alcohol diminishes the secretion of bicarbonate and water by duct cells but 
increases protein secretion by acinar cells, so producing juice that is abnormally 
viscous. The ductal plug hypothesis proposes that eosinophilic protein plugs then 
form within interlobular and intralobular ducts, and these plugs enlarge and calcify 
with precipitation of calcium carbonate. Adherence of protein plugs to the ductal 
epithelium causes epithelial injury and periductal inflammation leading to fibrosis 
and stricture formation. Parenchymal atrophy occurs in the obstructed, inflamed part 
of the pancreas. The random formation of plugs at any level in the ductuloacinar 
system explains the multiple foci and patchy nature of chronic pancreatitis.  
A 13.5 KDa pancreatic stone protein, known as lithostatine is one of the most 
abundant nonenzyme proteins secreted by acinar cells and evidence suggests that, it 
normally prevents nucleation and growth of calcium carbonate crystals. Pancreatic 
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juice levels of lithostatine are decreased in alcoholics and are abnormally low in 
chronic pancreatitis, regardless of whether the disease is caused by alcohol or other 
agencies. Levels of messenger RNA encoding for lithostatine are reduced in all 
forms of chronic pancreatitis.  
Recent evidence that calcification may be absent from tissues showing early 
changes of chronic pancreatitis suggests that changes at the cellular level precede 
the lithogenic process. Mechanisms which could be involved before the formation 
of ductal plugs and their calcification include a direct toxic effect of alcohol on the 
cells, cellular adaptation to alcohol, and cytotoxic damage to the cell membrane.  
Other factors that could be implicated in calcification include increased secretion of 
calcium by acinar cells, and a decreased concentration of citrate in pancreatic juice. 
Secretion of the 69KDa protein lactoferrin may also be increased by alcohol and this 
iron - binding protein can associate strongly with acidic molecules to form 
complexes, potentially facilitating the formation of protein plugs. 
 
 
 
Toxic - metabolic hypothesis:  
Alcohol induces hepatic mixed function oxidases, and it has been postulated that 
disordered hepatic detoxification may generate toxic free radicals and reactive 
intermediates which are excreted in bile and reflux into the pancreatic duct system.  
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Thebody’s normal defences against oxidants such as free radicals consists of metal-
sequestering proteins (eg. lactoferrin, ceruloplasmin), antioxidantenzymes, micro- 
nutrients (acting in their native state or sustaining cellular stores of glutathione), and 
miscellaneous agents such as bilirubin. Depletion of micronutrients and other anti- 
oxidants has been implicated in alcoholic pancreatitis and in tropical pancreatitis.  
Cigarette smoking is now thought to promote alcohol induced pancreatic damage 
and could do so by increasing free radical generation while at the same time 
diminishing the levels of antioxidants such as vitamin C and carotene and the ability 
to scavenge free radicals. A unifying pathway in which oxidative stress has critical 
importance in the pathogenesis of chronic pancreatitis has been proposed by 
Braganza.  
 
Nutritional factors and chronic pancreatitis  
Tropical pancreatitis:  
TP is asyndrome characterized by abdominal pain, pancreatic calculi, and diabetes 
mellitus occuring in nonalcoholic individuals (H. Ramesh 1997). Thiscondition has 
a distinct epidemiological basis and etiology. It is found in countries within 150 of 
the equator. It is particularly common in the south Indian state of Kerala, where a 
large community- based field study suggests a prevalance of 1 per 793 inhabitants. 
This disease was first described in Indonesia by Zuidema. A similar syndrome was 
subsequently reported from other tropical countries, including Uganda, Malavi, 
Zaire, Srilanka, India, Nigeria and Brazil.  
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Although the morphological changes in tropical pancreatitis resembles those of 
calcific chronic pancreatitis due to alcohol, alcohol is not implicated etiologically. 
Tropical pancreatitis is characterised by recurrent abdominal pain beginning in 
childhood, adolescence, or early adult life, and by pancreatic calciflcation, exocrine 
pancreatic insufficiency and insulin-dependent diabetes mellitus. Whereas earlier 
hospital-based studies from India showed a male predominance, more recent 
community - based studies showed a female preponderance of 1.8:1. Pancreatic 
cancer is said to develop in 2.7 - 8.3% of cases. One study from India suggests that 
the relative risk of developing pancreatic cancer is 100. When cancer develops in 
patients with chronic pancreatitis,it does so at a relatively early age, the average age 
of onset in this series being 45.6 years.  
The major etiological factor was once thought to be protein - energy malnutrition or 
childhood kwashiorkor, but this is no longer accepted. 
Admittedly, pancreatic fibrosis can develop in kwashiorkor, but the pattern of 
prevalence of the two diseases does not always overlap and Kerala actually has the 
lowest infant mortality in India, despite its high incidence of tropical pancreatitis. It 
now seems likely that a dietary toxin, possibly in association with a diet deficient in 
protein and/or trace elements, is the major etiological factor.  
Cassava (Manihotesculenta) is a dietary staple in many tropical countries and 
contains the toxic cyanogeneticglycosides,linamarin and linamarase. Hydrocyanic 
acid is liberated when these glycosides are exposed to hydrochloric acid in the 
stomach, but in the presence of adequate amounts of cystine and methionine,it is 
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converted by the enzyme rhodanase to thiocyanates. Failure to detoxify cyanogens 
allows them to impair the actions of enzymes, such as free radical scavenger 
superoxide dismutase, with the possibility of cell injury. Cassava lacks methionine 
as well as protein, and the lack of trace elements such zinc, selenium, and copper 
may also impair detoxification.  
It must be emphasized that tropical pancreatitis has been reported in Individuals 
who have not consumed cassava. However, it remains probable that radical 
pancreatitis results when ingestion of toxins such as cyanogen - promoted radicals 
are not balanced by adequate intake of macronutrients and micronutrients. 
 
Chronic pancreatitis and kwashiorkor:  
Juvenile kwashiorkor may be associated with pancreatic atrophy, secretory 
insufficiency and abdominal pain, but calcification and duct changes are 
exceptional. The atrophy of kwashiorkor can be reversed by adequate nutrition, 
provided parenchymal fibrosis has not become too extensive.  
 
 
Obstructive chronic pancreatitis  
This form of chronic pancreatitis is due to ductal obstruction from a variety of 
causes. The obstructed part(s) of the gland show(s) uniform rather than  patchy 
inflammatory changes. Initially there is hypertrophy of the centroacinar md 
intercalated duct cells. Flattening of the acinar cells is then followed by acinar 
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atrophy and fibrosis in the obstructed pancreas. Inflammation is often relatively 
mild. Intraductal protein plugs are relatively unusual, and calcification with stone 
formation is rare. The non -obstructed part of the pancreas is usually normal. The 
importance of this type is that, when the obstruction is relieved, the pancreas may 
often revert to normal.  
 
Pancreas divisum  
This condition results when the dorsal and ventral pancreatic ducts fail to fuse 
and is the commonest pancreatic ductal anomaly with an incidence of 4-14%.  
The hypothesis has been advanced that in pancreas divisum, the minor papilla 
cannot readily transmit the relatively large volume of juice produced bythe dorsal 
pancreas. The hypothesis is supported by the finding that pressure within the dorsal 
duct in pancreas divisum is higher than in the normal main pancreatic duct. 
However, it is debatable whether pancreas divisum is really a cause of pancreatic 
inflammation.  
Although the available evidence now indicates that chronic pancreatitis is not 
more common in patients with pancreas divisum, a few patients with divisumhave 
been reported in whom chronic inflammation was confined to the dorsal pancreas. It 
may be that stenosis of the accessory papilla, rather than pancreas divisum alone is 
critical in determining whether pancreatitis will develop 
Obstruction due to neoplasia 
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Tumors in the pancreas or periampullary region are a recognised cause of 
acute pancreatitis, accounting for 1-2% of cases. They occasionally produce duct  
obstruction and chronic inflammation. Biochemical or clinical signs normally 
associated with chronic pancreatitis may be lacking, and diffuse pancreatic 
calcification and formation of ductal stones are extremely unusual. 
Obstruction due to ductal strictures 
Strictures of the pancreatic duct can develop after an attack of pancreatitis or trauma 
in which healing is associated with fibrotic scarring. Chronic obstructive 
pancreatitis has also been reported following healing of pseudocystsin acute 
pancreatitis. Papillary stenosis is a rare acquired form of ductal obstuction which 
can cause abdominal pain, but rarely progresses to chronic inflammation 
Miscellaneous causes of obstruction 
Unusual causes of obstruction include duodenal wall cysts, ectopic pancreatic tissue 
and obstruction by vegetable matter or parasites such as round worms 
(Ascarislumbricoides), liver flukes (clonorchissinensis), and hydatid. choledochal 
cysts, choledochoceles, alimentary tract duplications, and duodenal obstruction are 
further rare causes. Duplications, ductal anomalies and trauma are the outstanding 
causes of pancreatitis in children.  
Chronic pancreatitis associated with metabolic disorders 
Hypercalcemia 
There is a strong association between hypercalcemia and pancreatitis. In cases, the 
pancreatic inflammation is acute rather than chronic, and the attacks are precipitated 
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by acute hypercalcemic crises.  
Hyperlipidemia 
Hyperlipidemia may be associated with acute pancreatitis. But there is no  proven 
association with chronic pancreatitis, although hyperlipidemia can occur during 
acute exacerbations of chronic alcoholic pancreatitis. 
Familial chronic pancreatitis  
 Familial chronic calcific pancreatitis is a rare condition, first described in 
1952 by Comfort and Steinberg. The disease usually becomes manifest between 5 
and 15 years of age, and appears to be inherited as an autosomal dominant gene  of 
variable penetrance. The pathogenesis is far from clear, but decreased levels of 
lithostatine in the pancreatic juice have been found. Morphologically, the disease, 
resembles non- familial pancreatitis, and stone formation with duct obstruction are 
usually prominent features. The risk of developing pancreatic cancer is as as 25% in 
some families with hereditary chronic pancreatitis.  
Idiopathic chronic pancreatitis  
In 20-40% of patients with chronic pancreatitis, no etiological factor can be 
identified. 
Idiopathic chronic pancreatitis affects men and women equally. Juvenile 
idiopathic chronic pancreatitis has a median age of onset of 19 years and is a painful 
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condition which resembles alcoholic pancreatitis clinically, morphologically, and 
functionally, although pancreatic insufficiency and calcification develop more 
slowly. Late- onset idiopathic chronic pancreatitis is associated with weight loss, 
functional impairment, and pancreatic calcification,  
but almost 50% of patients experience no pain. A degree of pancreatic atrophy, 
fibrosis, and ductal stenosis with calcified stone formation is a feature of aging and 
late-onset chronic pancreatitis may be an exaggeration of this process.  
Chronic pancreatitis and biliary tract disease  
Although gallstones are the commonest cause of acute pancreatitis, they seldom if 
ever cause chronic pancreatitis. Despite this, almost 50% of patients with gallstones 
have an abnormal pancreatogram if they undergo ERCP, although these are usually 
minor changes and only one in six patients have changes  suggestive of chronic 
pancreatitis. While biliary tract disease is not an important of chronic pancreatitis, 
cholestasis is a recognised complication of  pancreatic inflammation and may result 
from compression of the common bile duct by edema, fibrosis, and cysts or 
pseudocysts.  
Miscellaneous causes  
Abdominal radiotherapy:  
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Patients who have received radiotherapy for intra abdominal malignancy  
may be at increased risk of developing chronic pancreatitis after a latent interval of 
upto 20 years, despite the fact that the pancreas is normally regarded as resistant to 
radiation injury. 
Cystic fibrosis:  
In long - standing cystic fibrosis, the pancreas becomes small, firm and nodular, and 
intraluminal eosinophilic concretions obstruct the smaller pancreatic ducts ,with 
disruption of acini and their replacement by fibrous tissue and small  cysts. 
 
Cholangitis and Primary biliary cirrhosis:  
Pancreatic insufficiency is occasionally reported in association with ulcerative 
colitis and pericholangitis. The associated pancreatic secretory insufficiency in 
biliary cirrhosis has fuelled the suggestion that the cholestasis, salivary and lacrimal 
hyposecretion and pancreatic hyposecretion are part of  a ‘ dry gland’ syndrome in 
this disease. 
 
CLINICAL FEATURES 
Clinical tetrad of abdominal pain, weight loss, diabetes mellitus and steatorrhoea is 
a classic presentation in patients with chronic pancreatitis. 
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1. Pain  
Pain  is the outstanding symptom in the great majority of patients (95%). A 
careful history will define the nature of the pain and serve as a vital first step 
in getting to  know the patient and establishing the rapport which is so 
essential for long term success.  
The potential causes of pain in chronic pancreatitis are,  
a) Pancreatic ductal hypertension  
b) Inflammation of intrapancreatic nerves  
c) Loss of protective perineural sheath in pancreatic nerves.  
d) Pancreatic ischemia  
e) Pancreatic and peripancreatic infection.  
f) Pseudocyst of the pancreas  
g) Biliary obstruction  
h) Cholangitis  
i) Duodenal obstruction 
The site of pain depends to some extent on the main focus of disease and it 
may be experienced in the epigastrium or subcostal regions. The pain frequently 
through to the back, either centrally or to one or both sides. In some patients back 
pain predominates, while in others the pain is more diffuse. In the rare event that 
pain radiates to the shoulder, it usually does so on the left. Many  patients find that 
certain positions afford relief some lean forward and avoid flat on their back, while 
others lie curled up and avoid lying on a particular  side. In extreme cases the 
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patient may kneel on all fours in attempts to gain relief.  . Some find that a hot bath 
or the application of a hot water bottle or heat pad  provides relief. The attack of 
pain is frequently associated with anorexia & nausea but vomiting rarely brings 
relief.  
The pain is usually described as a dull gnawing ache and is seldom colicky. 
Some patients find that the pain is triggered by large meals or food with a high fat 
content. In others, bouts of pain are associated with drinking alcohol.  
However there is often no clear relationship between oral intake and pain, 
although many patients reduce their intake substantially during an attack. The 
patient  may complain of intermittent attacks, which last for hours or days, while  
some consider that they are never really free of pain. 
Pointers towards severity of pain are,  
(a) Loss of sleep  
(b)  Time off work  
(c)  Need for admission to hospital  
(d) Need for analgesics.  
By the time of referral, many patients are already taking opiates, and in  some 
case addiction may already be established. Assessment of pain is one of  the most 
difficult aspects of management, particularly in patients who are also addicted to 
alcohol or who have developed manipulative personalities in their  search for 
powerful analgesics. As a general rule, all patients with chronic pancreatitis should 
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be fully evaluated on an inpatient basis on atleast one occasion so that their pain can 
be assessed comprehensively.  
  
2. Steatorrhoea 
This occurs in about 30% of chronic pancreatitis patients. Steatorrhoea means that 
pancreatic lipase output has fallen to less than 10% of normal. . It is not an 
invariable feature. The patient should be questioned specifically about bowel habit, 
determining whether the stool is pale, bulky, oily and  particu1ar1y offensive in 
smell, and whether it floats on the surface of the water  and is difficult to flush 
away. Steatorrhoea can be socially incapacitating. Stool frequency and urgency may 
increase, but it is unusual for there to be more than 5 or 6 movements a day. Watery 
diarrhoea is unusual in chronic pancreatitis.  
 
Constipation  
Some patients develop constipation from high intake of analgesics.  
Diabetes mellitus  
This is a variable and relatively late manifestation. It usually develops sometime 
after the onset of overt exocrine insufficiency. Pancreatic endocrine function usually 
declines gradually, and dietary control of diabetes then has to be supplemented by 
oral hypoglycemic drugs and, ultimately, by insulin. Two-third of patients with 
chronic pancreatitis have abnormal GTT and half of them have DM 
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Weight loss  
Weight loss may reflect decreased oral intake, exocrine insufficiency, and 
underlying chronic alcoholism. Weight loss, may be seen in about 75% of  patients 
 
Jaundice  
Patient may be jaundiced due to biliary tract obstruction.  
Vomiting  
Patientmay develop vomiting due to duodenal stenosis.  
 
Gastrointestinal bleeding  
This may be caused by splenic vein thrombosis and the development of gastric and 
esophageal varices, or by erosion of pancreatic and peripancreatic arteries by 
inflammation.  
 
CLINICAL EXAMINATION  
There is no pathognomonic physical signs in chronic pancreatitis. Malnutrition and 
weight loss may be evident. Burn marks on the abdomen and  back indicate the use 
of heat pads and hot water bottles to relieve pain. In complicated disease, the patient 
may have jaundice due to common bile duct obstruction, a visible or palpable 
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abdominal mass or an enlarged spleen (splenic  vein thrombosis and left - sided 
portal hypertension). Stigmata of chronic liver  diseaseand hepatic decompensation 
are relatively uncommon. On rare occasions, patients present with pancreatic ascitis 
or pleural effusion as a consequence of rupture of the duct system or of a 
pseudocyst.  
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COMPLICATIONS  
The complications of chronic pancreatitis are,  
Pain  
Exocrine insufficiency  
Endocrine insufficiency  
Pseudocyst of pancreas  
Pancreato - cutaneous fistula  
Pancreatic ascitis 
Pleural effusion  
Common bile duct obstruction  
Duodenal obstruction  
Colonic obstruction  
Left sided portal hypertension  
Pancreatic haemorrhage 
Pancreatic carcinoma  
 
Differential diagnosis: Pancreatic cancer  
Usually the diagnosis of chronic pancreatitis is straight forward. Most are chronic 
alcoholics with recurring episodes of abdominal pain, diabetes mellitus , weight 
loss, pancreatic calcification and malabsorption. But distinction between chronic 
pancreatitis and pancreatic cancer may be very  difficult ,especial1y when there is 
no previous history of pancreatitis, patient presents with jaundice, pain is not a 
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prominent symptom and weight loss is significant. Surgery may be necessary to 
make a diagnosis. 
INVESTIGATIONS  
Methods used to diagnose and assess chronic pancreatitis  
Used routinely  
History and clinical examination  
Plain X-ray abdomen  
UGI Scopy 
Ultrasonography  
CT-Scan  
ERCP  
Value debated  
Laboratory investigation  
Endocrine function tests  
Exocrine function tests (Direct and Indirect)  
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Nuclear magnetic resonance imaging  
Used in specific circumstances  
Percutaneous fine-needle cytology/histology  
Hypotonic duodenography 
Barium enema and colonoscopy 
Angiography  
Doppler ultrasonography  
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No single test is sufficiently sensitive and specific to establish the diagnosis 
of chronic pancreatitis. Much depends on a careful history and clinical 
examination, supplemented by the selective use of investigations.  
 
Plain X-ray abdomen:  
This reveals pancreatic calcification in 30-50% of chronic pancreatitis 
patients. When calcification is present, the diagnosis of chronic pancreatitis is 
certain, even if there is no clinical evidence of pancreatic disease. Pancreatic 
calcification is 95% specific for chronic pancreatitis.  
UGI Scopy:  
This should be done to know whether the pain is produced only by chronic 
pancreatitis and not by duodenal ulcer.  
 
Ultrasonography:  
USG is a valuable first step to outline pancreas, to define its size, contour  
and texture. It reveals calcification, ductal dilatation, cysts, pseudocysts, 
abscesses and abnormalities of liver, biliary tree and spleen, fluid collections 
and  inflammatory masses.  
Dilatation of the pancreatic duct can be detected with a sensitivity of 60-70%. 
It is especially useful in cachectic, pregnant patients and  whenever repeated follow-
up examination is called for. But USG is operatorpendant, with a false negative rate 
of 25%. So it occupies second place after CT as a means of assessment.  
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CT SCAN 
This is the best method of detecting pancreatic calcification and provides most 
precise information about the size and configuration of pancreas. It is regarded as 
complementary to USG. CT gives information about the morphological changes, 
ductal anatomy, vascular anomalies and presence of complications (pseudocysts). It 
is especially useful when used in conjunction with dynamic bolus contrast 
enhancement. Spiral CT gives clear, reproducible findings with a false negative rate 
of only 7% When the duct is grossly dilated in CT scan, ERCP may be unnecessary. 
But considering the cost and hazards of radiation, it should be used sparingly. 
Ultrasonography or CT can be used for targeted percutaneous fine needle aspiration 
or biopsy of suspicious area, but exclusion of pancreatic cancer is frequently 
impossible without laparotomy and pancreatic resection.  
 
Endoscopic retrograde pancreatography (ERP):  
This is the single most effective method of detecting chronic pancreatitis and 
differentiating it from pancreatic cancer. It complements ultrasonography and CT, 
increasing the sensitivity and specificity of each investigation.  
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When all three investigations (USG, CT, ERP) are combined, a sensitivity of 95-
97% and specificity of 100% have been reported for diagnosis of chronic 
pancreatitis and pancreatic cancer.  
ERCP reveals typical findings - pancreatic and biliary ductal dilatation, defines 
filling defects caused by calculi, detects cysts and collections which communicate 
with pancreatic ductal system. ERCP is crucial in determining whether resection or 
drainage procedure is appropriate. It shows ductal dilatation with filling of 
secondary and tertiary branches in the early stages of the disease. The characteristic 
ERCP finding of ‘chain of lake’ appearance in chronic pancreatitis represents ductal 
dilatation together with ductal stricturing. An entirely normal pancreatogram in a 
patient with abdominal pain almost safely eliminates the diagnosis of chronic 
pancreatitis. Patients considered for surgical intervention should undergo ERCP. 
The characteristics of biliary stenosis in chronic pancreatitis is diffuse, longitudinal, 
symmetrical stricture of distal CBD with angulation, and is never complete. But in 
case of pancreatic carcinoma, the biliary stricture as seen in ERCP is shorter, 
asymmetric and complete. But ERCP fails to outline duct system in 5-10% of 
patients. It gives a correct diagnosis of chronic pancreatitis only in 90% of cases. So 
some surgeons do intraoperative pancreatography. 
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Pancreatic function test:  
Pancreatic secretory response to a standardized stimulus can provide information 
about the secretory capacity of the gland. Tests of pancreatic exocrine function can 
be subdivided into those in which the stimulus for secretion is indirect, as by 
ingestion of a test meal, and those in which it is direct, as by injection of a hormone. 
Pancreatic function tests are useful in patients with painless malabsorption.  
Exocrine function tests have little influence on indications for or against any 
operation. They rarely influence therapeutic decisions. They cannot distinguish 
pancreatic carcinoma from chronic pancreatitis. Most surgeons dealing with chronic 
pancreatitis rely on patients history of steatorrhoea as an index of exocrine 
insufficiency. But exocrine function tests are still useful when assessing new 
methods of treatment and to establish a baseline from which to monitor long-term 
effects of surgery.  
The diagnosis of diabetes mellitus is confirmed if random blood glucose 
values exceed l4mmol/l, and urine testing is useful to detect glucosuria and the 
presence of ketones. Glucose tolerance tests are usually reserved for patients with 
equivocal hyperglycemia. Levels of glycated hemoglobin A 1 (HbA 1) can be used 
to monitor the overall degree of control in patients with established diabetes. The 
decision to undertake a major resection is simpler, if the patient is already an insulin 
dependant diabetic.  
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Magnetic resonance imaging (MRI):  
MRI has so far not able to add anything that CT cannot provide. But with 
rapid sequence MRI, progress is expected.  
Cytological examination  
Percutaneous FNAC is indicated when carcinoma is suspected in patients with a 
inflammatory mass of head of pancreas, who are not fit for operation. Only the 
unequivocal detection of malignant cells is of any consequence. In patients who are 
fit for operation, doubt about the existence of cancer in an area of chronic 
inflammation is best resolved by resection, given the sampling error inherent to 
needle aspiration / biopsy.  
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Hypotonic duodenography:  
Thisinvestigation is superceded by endoscopy. It is occasionally used to 
assess the functional significance of duodenal stenosis. Barium enema and 
colonoscopy:  
These are indicated to evaluate colonic obstruction.  
Selective angiography:  
Selective angiography is done in patients with suspected arterial bleeding, to 
locate the source of bleeding and also to evaluate portal and splenic vein 
thrombosis.  
Arterial phase of angiography reveals pseudoaneurysm, defines source of 
bleeding in patients with haemorrhage into pancreatic duct or into pseudocyst. The 
portal venous phase, detects obstruction of splenic, superior mesenteric and portal 
vein. Angiography gives forewarning of congenital vascular anomalies that occur in 
20-30% of individuals. Dynamic CT however provides much of the information 
given by angiography.  
 
Doppler USG:  
This is done to evaluate portal and splenic thrombosis.  
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Serum enzymes  
Serum and urinary amylase and lipase levels frequently remain within the normal 
range in chronic pancreatitis, even during exacerbations, particularly when the 
disease has been present for several years. This is because the progressive 
destruction limits the amount of enzyme available and the chronic fibrosis limits 
permeability of ducts to enzymes.  
Serum amylase and lipase are helpful for the diagnosis of acute  
pancreatitis,but are of less value in chronic pancreatitis. But during early stages of 
chronic pancreatitis, serum amylase and lipase may rise during acute exacerbations. 
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TREATMENT  
Management of chronic pancreatitis patients may be either conservative or 
surgical.The clinical team usually includes a surgeon, gastroenterologist, radiologist, 
skilled nursing staff, diabetologist, psychiatrist, dietician and a social worker. The 
central role is played either by the surgeon or a gastroenterologist. About half the 
patients in most reported series have been managed conservatively.  
Conservative management of chronic pancreatitis  
Before embarking on conservative management, it is essential to  
(i) confirm, patient indeed has chronic pancreatitis  
(ii) establish cause, and if possible, eradicate it.  
(iii) assess the severity of disease, its complications, defining morphological and 
functional changes.  
(iv) exclude presence of accompanying disease, especially pancreatic cancer. 
 
 
(a)  Treatment of pain  
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Acute exacerbations of chronic inflammation may produce episodes of severe 
abdominal pain and tenderness. Serum amylase and lipase are increased  
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but not to the degree seen in acute pancreatitis. Acute exacerbations require 
hospitalization, with cessation of oral intake and the provision of intravenous fluids 
and appropriate analgesics. Any temptation to resort to surgery in such patients 
should be resisted. It is reasonable to maintain nutritional status by parenteral 
feeding for a trial period of 10-14 days.  
The treatment of chronic pain is one of the most difficult areas of clinical medicine. 
The failure to provide lasting pain relief remains the outstanding indication to 
abandon conservative management in favour of surgery. Useful strategem is to use a 
staged approach to prescription of analgesics. Stage 1 analgesics - principal 
analgesic being paracetamol, is effective in musculoskeletal pain, than visceral pain. 
Paracetamol 500-600 mg,every 4hrs, to a maximum of 3-4 g/day has fewer side-
effects. Stage 2 analgesics - principal analgesic being codeine. Weak opiods such as 
dihydrocodeine and codeine are suitable for patients with mild to moderate pain and 
are usually given orally, 30mg every 6hrs. Dextropropoxyphene, another weak 
opioid, can be combined with codeine or paracetamol. As opioids, these drugs can 
cause constipation, nausea, dizziness and respiratory depression.  
 
Buphrenorphine is used to treat moderate to severe pain and is normally 
given sublingually. Stage 3 analgesics - principal analgesic being morphine,is 
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prescribed for patients with severe pain. Oral morphine solution (oramorph 5-20mg 
every 4 hours) is generally preferred to diamorphine (heroin).  
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Nausea and vomiting can be prevented by antiemetics such as haloperidol or 
prochlorperazine. MST continus is a slow-release oral preparation which is useful 
for chronic severe pain. If increments are needed, they should be made to the dose, 
and not to the frequency of administration. Analgesic use must be kept under close 
surveillance, given the risk of dependance.  
A trial of somatostatin analogue, to inhibit pancreatic secretion, appeared to relieve 
pain in some patients. Percutaneous celiac plexus block and Endosonography 
guided chemical splanchnicectomy are other methods of non- operative palliation of 
pain.  
(b) Abstinence from alcohol  
Abstinence from alcohol is a crucial determinant of long -term outcome. It should 
be emphasized repeatedly to the patients and his relatives. Every assistance should 
be provided including counselling, social review, psychiatric consultation, and the 
use of mutual - support groups such as Alcoholics Anonymous. Although all would 
recommend abstinence in alcohol-related chronic pancreatitis, it is doubtful whether 
it brings pain relief or arrests further functional deterioration. Serial ERP in chronic 
alcoholic pancreatitis has shown that ductal changes may progress despite 
abstinence or reduced alcohol intake. Many studies have confirmed the poor-
prognosis of alcoholic chronic pancreatitis.  
(c) Dietary considerations:  
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Patients with chronic pancreatitis should avoid a high-fat, high-protein diet and 
large meals, in order to reduce stimulation of the pancreas by CCK. It has been 
suggested that pancreatic exocrine supplements contribute to pain relief by reducing 
the pancreatic secretory response to food through negative feedback mechanism. 
But there is some evidence that pancreatic enzyme extracts actually stimulate 
pancreatic secretion through release of CCK. Some consider that free- radical 
formation can have central importance in chronic pancreatitis, and argue that 
antioxidants such as selenium and vitamins A,C and E may be of value.  
(d) Treatment of Steatorrhoea:  
Failure of pancreatic exocrine function leads to excessive loss of fat 
(steatorrhoea) and protein (creatorrhoea) in the stool. This is a major contributor to 
weight loss and muscle wasting. Pancreatic insufficiency affects fat absorption more 
than carbohydrate and protein, since protein digestion is aided by gastric pepsin and 
carbohydrate digestion aided by salivary amylase.  
All currently available pancreatic enzyme supplements consists of crude 
extracts of porcine pancreas, known as ‘pancreatin’. A major drawback is that some 
90% of the enzyme activity is lost during passage through the stomach, the enzymes 
being rapidly and irreversibly inactivated at pH values below 5. 
Preparations are available in which tablets or granules are coated in an enteric 
coating which dissolves above pH 6. Recently, enteric-coated microspheres have 
been developed in which hundreds of individually coated microspheres are 
contained in a gelatin capsule. The particles are released within the stomach, pass 
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readily into the duodenum because of their small size (<2mm), and then lose their 
enteric coating when exposed to pH values around 6. Pancrease and Creon are 
preparations of enteric - coated microspheres of pancreatin. The capsules are 
swallowed whole with meals, or opened to allow granules to be taken with fluid or 
soft food. One or two capsules are taken with meals in the first instance, the dose 
being increased as necessary, usually to some 10-15 capsules daily. The diet should 
supply 3 000-6000 kcal/ day, carbohydrates more than 400 gm, protein 100-150 gm, 
fat restricted to less than 50gm per day and pancreatic enzyme replacement 
containing atleast 30,000 units of lipase, four times a day. If steatorrhoea does not 
respond to oral pancreatic enzyme supplements, duodenal pH can be raised by 
prescribing H2 - receptor antagonists such as ranitidine (150 mg twice daily). If 
steatorrhoea is still troublesome, fat intake can be reduced to approximately 
50glday, and the diet supplemented with medium - chain triglycerides. 
 
(e) Treatment of Diabetes mellitus:  
DM usually develops after exocrine insufficiency has become manifest. A 
mild increase in blood sugar does not require treatment. A fasting blood sugar> 
250mg% requires treatment with insulin. Rigid control of blood sugar is not 
advisable. It is sufficient to maintain a fasting blood sugar around 200mg% Dietary 
control of DM has to be supplemented by oral hypoglycemic drugs and ultimately 
by insulin. In patients requiring insulin, the accompanying lack of endogenous 
glucagon secretion results in insulin sensitivity and a greater risk of hypoglycemia. 
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Conversely, the risk of diabetic ketoacidosis is minimal, as there is usually enough 
insulin secretion to prevent fatty acids being released from adipose tissue and 
metabolised to ketone bodies in the liver.  
 
 
 
(f) Treatment of malnutrition  
The patient may be afraid to eat because of pain, may have steatorrhoea and 
creatorrhoea because of pancreatic dysfunction, and may have nutritional 
problems associated with chronic alcoholism. Vitamin supplementation may 
be needed , particularly in alcoholics. Deficient fat intake or excessive loss 
can be countered by increased protein and carbohydrate intake. Regular 
involvement of a dietician is advisable, and nutritional status should be 
monitored regularly. 
(g) Treatment of Complications:  
Duodenal and colonic obstruction can often be treated conservatively, unless 
it is obvious that a fibrotic stricture has developed. Biliary tract obstruction is 
rarely an isolated indication for surgery, but operation is indicated if there is 
persistent obstructive jaundice for more than 4 weeks or cholangitis. 
Intervention is usually recommended when a pseudocyst fails to resolve after 
6 weeks of conservative management. Percutaneous drainage offers an 
alternative to surgical or endoscopic drainage of persistent pseudocysts. 
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Pancreatic ascitis and pleural effusions are relatively rare spontaneous 
complications of chronic pancreatitis  
Conservative management consists of stopping oral intake, repeat 
paracentesis or pleural drainage, and parenteral nutritional support. The long 
acting somatostatin analog octreotide (50-100 Micro gram  two or three 
times daily, SC) is prescribed.  
 
Surgical treatment for chronic pancreatitis  
Before any operative procedure is even considered, it is essential to confirm 
that the diagnosis of chronic pancreatitis is correct, and that the cause has 
been established where possible, determine the severity of the disease, and 
the presence of complications. Chronic pancreatitis is not a surgical disease. 
It seems improbable that any surgical intervention can reverse or 
significantly slow this process, despite some reports to the contrary. It is 
when medical treatment fails, based as it mainly is on analgesics, dietary 
restrictions, and substitution therapy for loss of function, that many patients 
are finally referred to the surgeon. The main objectives of surgery are, to 
ameliorate intractable pain, to deal with the complications of the disease and 
to rule out the presence of carcinoma. Pain and obstructive complications 
usually require elective surgery, whereas erosion of either the pancreatic duct 
(ascitis, pleural effusion) or peripancreatic vessels may require emergency 
intervention.  
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Indications for operation:  
1. Intractable pain  
2.  Complications of chronic pancreatitis  
(a) Biliary obstruction  
(b) Duodenal stenosis (colonic stricture)  
(c) Pancreatic duct stenosis  
(d) Pseudocysts 
(e) Pancreatic ascitis , pleural effusion  
(f) Portal venous compression  
(g) Pancreatic haemorrhage 
3. Suspicion of pancreatic carcinoma 
 
Intractable pain  
Intractable pain that significantly affects quality of life, leads to drug addiction, and 
causes inanition because the patient is afraid to eat, is an indication for operation by 
itself.  
Biliary Stenosis:  
Stenosis of the common bile duct occurs in 30-65% of patients in most series. It 
almost always involves the retropancreatic portion of the common duct. It is seldom 
complete. It is characterised by long, narrow stricture, the ductal diameter usually 
being less than 1.5 cm. However if biliary obstruction is symptomatic (i.e. causes 
jaundice and pain), relief should be sought. Endoscopic transpapillary drainage by 
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means of a stent is indicated only as a temporary measure. Stenting for 1-3 months 
can be used to identify the subgroup of patients in whom the stricture may regress; 
when the stricture persists, surgical drainage is the procedure of choice for younger 
patients. Surgery is indicated if jaundice persists for >1 month. Bradley and Salam 
advocated choledochoduodenostomy, but the anastomosis depends on a well-dilated 
duct for longterm patency. Hollands and Little had satisfactory results with 
cholecystojejunostomy, whereas most authors, fearing cholangitis, prefer a 
hepaticojejunostomyutilising a long Roux-en-Y loop. 
Duodenal stenosis 
Duodenal stenosis occurs in < 1% of patients. Fibrotic, and possibly ischemic 
changes in the duodenal wall, leading to irreversible stenosis with vomiting and 
inanition are relatively rare and requires a bypass. This is best achieved if 
gastrojejunostomy is combined with some form of vagotomy to avoid peptic 
ulceration. However, duodenal stenosis is rarely an isolated complication so that, 
here too, pancreatoduodenectomy provides the optimal solution in many cases.  
Colonic Stricture;  
A colonic stricture, which may mimick carcinoma, rarely complicates chronic 
pancreatitis. Carcinoma has to excluded by colonoscopy. When fibrosis and 
ischemia cause irreversible changes and chronic ileus, this can only be relieved by 
segmental resection of the affected colon.  
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Pancreatic duct stenosis/ obstruction:  
Patients can be divided into two groups with respect to pancreatic duct pathology: 
those with a dilated duct system and those with so-called ‘small-duct disease’. With 
a duct dilatation of atleast 7mm in diameter, some drainage procedure is indicated. 
Currently a long side-to-side pancreaticojejunostomy, reaching as far as possible 
into the head of the pancreas and avoiding splenectomy and any loss of pancreatic 
parenchyma, is the method of choice. Extending the decompression by local 
resection of part of the anterior aspect of the pancreatic head may well improve the 
results of longitudinal pancreaticojejunostomy.  
Pancreatic cysts and pseudocysts 
Pseudocysts of less than 6cm in diameter can be safely observed for a period of upto 
6 weeks, particularly if they are asymptomatic. Percutaneous cyst aspiration is 
followed by recurrence in almost 70% of cases. Another alternative is endoscopic 
transgastric cyst drainage by means of a stent. Previously, operative treatment was 
indicated as a rule for all pseudocysts of more than 6cm in diameter, that showed no 
signs of resolution within a 6 week observation period. But now this concept has 
changed. Depending on cyst location, drainage is achieved by anastomosing the 
stomach, duodenum or Roux-en-Y loop of jejunum to the lowest point of the cyst 
wall. For cysts situated near the tail of the pancreas, resection is often the best 
solution. 
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 Pancreatic ascites and pleural effusion:  
Pancreatic ascites is due to leakage from the pancreatic duct or a pseudocyst. If 
conservative treatment (for 2-3 weeks) fails, intervention is indicated. Appropriate 
management depends on an accurate localization of the leak (by ERCP) and, when 
surgery is needed, it may take the form of resection or internal drainage of the 
fistula into a Roux-en-Y loop of jejunum. Pleural effusions will dry out once the 
abdominal cause has been eradicated.  
Portal venous obstruction:  
Involvement of the portal vein and its two main tributaries ranges from mild 
compression to complete occlusion with thrombosis, portal hypertension, cavernous 
transformation of peripancreatic veins, and esophageal varices which may bleed. 
Mild to moderate degrees of portal venous stenosis may be an indication for 
decompression. But portal or superior mesenteric venous thrombosis with portal 
hypertension and cavernous transformation of the peripancreatic veins is considered 
to be a contraindication to any procedure, since such an operation is prohibitively, 
haemorrhagic. In ‘segmental portal hypertension’ due to thrombosis confined to the 
splenic vein, best solution is splenectomy and resection of the pancreatic tail before 
major haemorrhage occurs.  
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Pancreatic haemorrhage:  
Changes in the peripancreatic arteries range from increased tortuosity to 
pseudoaneurysms and erosion, with massive haemorrhage. Bleeding may take the 
form of ‘hemosuccuspancreaticus’ or more commonly, bleeding occurs into a 
pseudocyst. Bleeding into a pseudocyst or pseudoaneurysm formation can now be 
detected on dynamic CT scanning if intravenously administered contrast is seen to 
leak. Emergency angiography is indispensible to locate the source and, if possible, 
obliterate it,by embolisation through the same catheter.  
Suspicion of pancreatic cancer:  
Inspite of the fact that sophisticated radiological methods, fine-needle cytology, and 
endoscopic ultrasonography are at our disposal, there are still some 15% of cases in 
which it is impossible to say whether a symptomatic mass in the head of the 
pancreas is inflammatory or malignant. The surgeon confronted with a symptomatic 
mass in the pancreas should resect it, even if proof of malignancy is lacking, 
provided that resection can be undertaken without undue risk.  
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Surgical treatment of chronic pancreatitis  
 
Indirect procedures  Direct procedures  
 
Gastric: Biliroth II  gastrectomy  
Selective proximal vagotomy (SPV) 
Gastrojejunostomy 
Drainage:  
External cyst drainage  
Internal cyst drainage (to stomach, duodenum 
or jejunum)  
Biliary:  
Cholecystectomy  
Sphincteroplasty 
Bilioenteric anastomosis  
Pancreaticojejunostomy:  
Retrograde drainage with splenectomy 
Lateral side-to-side drainage.  
Denervation:  
Splanchnicectomy 
Celiac ganglionectomy 
Total denervation of pancreas  
Denervated pancreatic flap (Warren)  
Resection:  
Distal Pancreatectomy(40-95%)  
Pancreatoduodenectomy 
         Standard Whipple  
         Pylorus preserving  
Total pancreatectomy 
Duodenum - preserving resections  
        Partial resection of head of pancreas  
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         Total resection of pancreas  
Longitudinal V-shaped excision of the 
ventral pancreas (Izbicki)  
Resection with autotransplantation.  
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Drainage operations in chronic pancreatitis  
Drainage operations can be classified into three types:  
1. Pancreaticojejunostomy (most frequently employed)  
2. Pancreaticogastrostomy 
3. Sphincterotomy and sphincteroplasty.  
Pancreatico jejunostomy:  
This is feasible if the pancreatic ductal diameter in the head and body is 
greater than 7-8mm. In the Du Val operation, the tip of the pancreas is transected 
and the spleen removed prior to creating an end-to-end anastomosis between the cut 
end of the pancreatic remnant and a Roux loop ofjejunum.  
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Puestow and Gillesby unroofed the main pancreatic duct from the tail to just 
beyond the neck of the pancreas. The body and tail of the gland are then implanted 
into the open end of a Roux loop ofjejunum. Partington and Rochelle opened the 
pancreatic duct as widely as possible, with extension of the incision into the head 
and uncinate process. A side-to-side pancreaticojejunal anastomosis is then created 
between the open pancreas and a Roux loop of jejunum, the advantage being, none 
of the pancreas is resected and the spleen remains in place. Pancreaticojejunostomy 
described by Frey and Smith resembles conventional pancreaticojejunostomy, but 
the head of the gland is cored out rather than simply incised before anastomosis to 
the Roux loop ofjejunum.  
Technical considerations and Results in Pancreaticojejunostomy: Ductal 
morphology should be defined prior to surgery by ERCP. Information regarding 
duct size can be obtained by USG or CT. The success of drainage surgery is due to 
the associated pancreatic ‘fasciotomy’ and relief of ischemic pain. During surgery, 
the duct in opened as widely as possible and all contained calculi are removed 
meticulously. PJ has an appreciably lower operative mortality and morbidity than 
does pancreatic resection. The chances of complete/substantial relief of pain at 5 yrs 
after surgery is 70%. The patients should not be encouraged to expect significant 
improvement in exocrine and endocrine function.  
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As the majority of patients with tropical pancreatitis have dilated ducts, drainage is 
usually preferred to resection, if surgery becomes necessary.  
 
Pancreaticogastrostomy:  
Pancreaticogastrostomy has been preferred to PJ by some surgeons, but it is difficult 
to know whether pancreaticogastrostomy has a place in management of chronic 
pancreatitis. 
Sphincterotomy and sphincteroplasty:  
Endoscopic attempts to improve drainage through the papilla of Vater have given 
encouraging results. Available techniques include sphincterotomy of the main or 
accessory papilla, insertion of a naso-pancreatic drain, introduction of a stent to 
drain the pancreatic duct or occlude a pancreatic fistula, and removal of duct calculi. 
Sphincterotomy at the major papilla is occasionally indicated to deal with the rare 
problem of papillary stenosis, but is more often used as a prelude to stone extraction 
or stenting. The technique resembles that used for biliary sphincterotomy, except 
that, the direction of cut is towards the 2’O clock position. Pancreatic duct stenting 
is the commonest endoscopic procedure performed in chronic pancreatitis. The 
chance of success is more in case of a single defined stricture. Other indications 
include pancreas divisum, pancreatic ascites and fistula. Self expanding metal stents 
should not be used as they become impossible to remove when blockage occurs.  
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Resection operations in chronic pancreatitis  
Distal pancreatectomy:  
Distal pancreatectomy can be subdivided into 80-95% pancreatectomyand <80% 
pancreatectomy. In 80-95% pancreatectomy, major portions of the head anduncinate 
process are excised, as well as the body and tail of the gland. In < 80% 
pancreatectomy, the greatest amount of the pancreas that is removed is the neck, 
body, and tail, and a small portion of the head.  
Partial Pancreaticoduodenectomy:  
The major indications for partial pancreatoduodenectomy with removal of the head 
of the gland are, disease that is appreciably more advanced in the head than in the 
body and tail and absence of pancreatic duct dilatation. ERCP and CT of the 
pancreas are invaluable in making this assessment. Secondary indications for 
resectional procedures of the right half of the pancreas, duodenum, and distal bile 
duct include obstruction of the bile duct and/or duodenum.  
The various partial pancreaticoduodenectomy procedures available are the 
standard Whipple procedure, the pylorus - and gastric-presering variant of the 
Whipple operation and the Beger procedure. The pyiorus and gastric preserving 
variant of the Whipple operation was first performed in 1944 by Watson and 
reported subsequently by Traverso and Longmire in 1978. The Beger procedure, 
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reported first in 1980, involves a less extensive resection of the head of the pancreas 
with preservation of the duodenum and distal bile duct, thus avoiding duodenal or 
gastric and biliary anastomoses. Arranged in decreasing levels of magnitude of 
resection, the variants of partial pancreatecomy procedure are the standard Whipple 
operation, the pylorus-preserving procedure (Longmire - Traverso), and the 
duodenum-preserving or Beger procedure.  
The duodenum-preserving procedure appears superior to the Whipple 
procedure and may be superior to the pylorus preserving procedure. The superiority 
probably does not extend to relief of pain, but may involve other parameters, 
namely postoperative mortality, development of diabetes and late mortality.  
Total pancreatoduodenectomy:  
Total pancreatectomy is an operation of last resort in that it is a procedure for 
patients who have not responded to medical management and in whom previous 
operative approches have failed. Therefore, it is not surprising that the clinical 
results are poor, and it must be considered as a salvage procedure after which half 
the patients return to a relatively normal existence. On this basis it is an appropriate 
operation to undertake, but only after careful assessment, and due recognition that 
the patient will need life-long monitoring.  
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Pancreatic transplantation:  
To avoid diabetes mellitus in patients subjected to total or near total 
pancreatectomy, autografts of the body and tail of the pancreas have been done. The 
splenic artery and splenic vein should be preserved for anastomosis with 
iliac/femoral vessels. Pancreatic islet cell auto transplantation via portal vein, into 
the liver is being done in a few centres around the world.  
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OBSERVATION 
Chronic pancreatitis is a chronic inflammatory disease characterised by irreversible, 
progressive destruction of the pancreatic tissue. The mean age of presentation in our 
study was 38.45 yrs, which correlates well with most others studies. The disease has 
a world wide distribution. In India, the state of Kerala has the highest incidence, 
accounting for 0.145% of the total hospital admission and 5.47% of all autopsies in 
Trivandrum district. It is also common in Tamilnadu. The incidence of the disease 
seems to taper off from the south towards the north.  
In our analysis of 24 patients of chronic pancreatitis at Thanjavur Medical 
College Hospital, Thanjarur, the patients have come from,  
1. Thanjavur - 4  
2.  Trichy -3  
3. Ariyalur - 3  
4. Thiruvaiyaru - 3  
5. Orathanadu - 3  
6. Needamangalam - 2  
7. Kudavasal - 2  
8. Pattukkottai - 1  
9. Mayiladuthurai - 1  
10. Tharagambaadi - 1  
11. Musiri -1  
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Age  
Chronic pancreatitis may occur at any age. The heriditary form manifests between 
5-15 years whereas the late - onset idiopathic chronic pancreatitis usually manifests 
after 50 years. In our study of 24 patients, the age wise distribution of patients was 
as follows:  
1. 10-20 years - 2  
2.  21-30 years - 5  
3.  31-40 years - 5  
4.  41-50 years - 9  
5. >51 years - 3  
In our study, the age of the youngest patient was 17 years and the oldest was 
53 years.  
 
Sex  
In our study, there were 19 males and 5’females, giving a sex ratio of 4:1, in 
favour of males. The sex ratio of 4:1 was also confirmed by a study conducted 
by Anand B.S in Delhi.  
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Religion  
Among the 24 patients, majority belonged to the Hindu community (22/24), one 
from Christian, and one from Muslim community.  
Plain X-ray abdomen revealed pancreatic calcification in 9 patients (37.5%). 
Ultrasonogram and CT scan revealed a dilated main pancreatic duct in 9 patients.  
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INCOME 
 One of the causes attributed for chronic pancreatitis in the tropics was 
protein-energy malnutrition as the disease is found generally in the low income 
group. Almost all the patients in our study belong to the lower socio economic 
group. This could be because of the referral bias, the affluent seeking treatment at 
private hospitals.  
 Alcoholic chronic pancreatitis accounted for 66.6% of the cases (16/24). 
Tropical pancreatitis accounted for 16.6% of the cases (4/24). Tropical pancreatitis 
patients had recurrent abdominal pain since childhood, were diabetic and plain x ray 
abdomen revealed pancreatic calcifications. Hospital based studies from India 
showed a male predominance in tropical pancreatitis, but recent community based 
studies showed a female preponderance of 1.8 :1. In our study, the sex ratio was 1:1. 
In the rest of the cases(4/24), since no etiological factors could be found out, these 
patients were grouped under idiopathic chronic pancreatitis. 
 Pain was the outstanding symptom in the great majority (22) of patients 
(91.6%), 6 patients (25%) had diabetes mellitus, 2 patients had steatorrhoea (8.3%). 
5 patients presented with abdominal pain and abdominal fullness / lump (20.8%) 
 Plain x ray abdomen revealed pancreatic calcification in 9 patients (37.5%). 
Ultrasonogram and CT scan revealed a dilated main pancreatic duct in 9 patients 
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Management  
Not all patients with chronic pancreatitis require surgery and half of the 
patients in many reported series have been managed conservatively. But in our 
study only 9 out of 24 (37.5%) patients were treated conservatively. This may be 
because of referral bias to our surgical department, ie., these patients were first 
treated medically and subsequently referred to surgical side following failure of 
medical management. Of the 24 patients, 9 patients had dilated main pancreatic 
duct. Of these 9 patients, 3 were managed conservatively and the rest (6 patients) 
underwentpancreaticojejunostomy. 8 patients with pseudocyst of the pancreas, with 
history and investigations suggestive of pseudocyst developing in chronic 
pancreatitis, underwent cystogastrostomy. Patients developing pseudocyst of the 
pancreas as a result of acute pancreatitis were not included in our study.  
Percutaneous celiac plexus block was done in one patient with 6% phenol. 
Patient had good postoperative pain relief, but he developed paraperesis which 
resolved gradually. During our short follow-up of operated patients, almost all 
patients experienced appreciable pain relief. Our patients were not encouraged to 
expect significant improvement in exocrine and endocrine function after surgery.  
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Three of operated patients developed minimal wound infection, which was easily 
controlled. Resection operation was not done, as none of our patients suited the 
indications. In our series of 24 patients, we did not come across any case of chronic 
pancreatitis due to gallbladder disease.  
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CONCLUSION  
Though chronic pancreatitis is not a surgical disease primarly, surgery is indicated 
when medical treatment fails and/or complication arises. There is no single ideal 
operation for chronic pancreatitis. More important is the selection of an appropriate 
method of management for a particular patient.  
Broadly, patients with chronic pancreatitis can be divided into (i) those with dilated 
duct disease >7mm in diameter and (ii) those with parenchymal disease. For those 
patients with dilated pancreatic duct, pancreatic drainage procedure is the apt one. 
For patients with localised parenchymal disease and normal sized duct, resection 
procedures are indicated. For patients with diffuse parenchymal disease and normal 
sized duct, denervation procedures are the best option.  
In our analysis of 24 patients of chronic pancreatitis, 16 patients were alcoholics, 4 
had Tropical pancreatitis and the rest of the 4 patients suffered from Idiopathic 
chronic pancreatitis. 22 patients had predominant abdominal pain, 6 patients had 
diabetes mellitus and 2 patients had steatorrhoea. 18 patients had either glandular or 
ductal calcification. 8 patients underwent cystogastrostomy with good pain relief.  
 
Pancreaticojejunostomy was done in 6 patients with good postoperative pain relief. 
One patient who underwent celiac plexus block had excellent post operative pain 
relief. 
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PROFORMA 
Name      sex 
Income      IP no. 
Address      Age 
Religion  
History:  
h/o abdominal pain 
h/o  alcoholism  
h/o diabetes mellitus  
H/o other presentations (GOO/Jaundice)  
H/o abdominal lump/fullness  
History suggestive of steatorrhoea 
Diet history  
Family history  
Investigations:  
Urine sugar  
Blood sugar  
Blood grouping  
Serum Amylase  
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Serum Calcium  
Plain X-ray abdomen  
USG abdomen  
CT scan-abdomen  
 
Treatment:  
Medical  
Surgical  
- Indications  
- Per operative findings  
- Post operative follow - up  
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